IMCD to acquire South Korean based Whawon Pharm Co. Ltd.

ROTTERDAM, The Netherlands (November 4, 2019) – IMCD N.V. ("IMCD” or "Company”), a leading distributor of speciality chemicals and food ingredients, today announces that it signed an agreement to acquire 57% of the outstanding shares of South Korean based pharmaceutical ingredient distributor Whawon Pharm Co. Ltd. ("Whawon”).

Initially, IMCD will acquire 57% of the total share capital from the existing Whawon management, who will continue to lead the company. The remaining 43%, will be maintained by the management, for a period up to 5 years after closing.

Attachment

• PRESS RELEASE _IMCD to acquire South Korean based Whawon Pharm Co. Ltd.